<HTML>
<HEAD>
<TITLE></TITLE>
</HEAD>
<BODY>
<PRE>
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549



                                    FORM 8-K


                Current Report Pursuant to Section 13 or 15(d) of
                       the Securities Exchange Act of 1934



       Date of Report (Date of earliest event reported): <u>October 28, 2005</u>


                        Blonder Tongue Laboratories, Inc.
             (Exact Name of registrant as specified in its charter)



          <u>Delaware</u>                       <u>1-14120</u>                   <u>52-1611421</u>
  (State or other jurisdiction    (Commission File Number)     (I.R.S. Employer
        of incorporation)                                    Identification No.)


                <u>One Jake Brown Road, Old Bridge, New Jersey 08857</u>
               (Address of principal executive offices) (Zip Code)



       Registrant's telephone number, including area code: (732) 679-4000


                                 <u>Not Applicable</u>
          (Former name or former address, if changed since last report)


Check  the  appropriate  box  below  if the  Form  8-K  filing  is  intended  to
simultaneously  satisfy the filing obligation of the registrant under any of the
following provisions:


[_]  Written  communications  pursuant to Rule 425 under the  Securities Act (17
     CFR 230.425)


[_]  Soliciting  material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
     240.14a-12)


[_]  Pre-commencement   communications  pursuant  to  Rule  14d-2(b)  under  the
     Exchange Act (17 CFR 240.14d-2(b))


[_]  Pre-commencement   communications  pursuant  to  Rule  13e-4(c)  under  the
     Exchange Act (17 CFR 240.13e-4(c))





<b>ITEM 1.01.  ENTRY INTO A MATERIAL DEFINITIVE AGREEMENT.</b>


On October 28, 2005, Blonder Tongue  Laboratories,  Inc. (the "Company") entered
into a commitment  letter with  National City Business  Credit,  Inc.  ("NCBC"),
pursuant to which NCBC  committed to provide to the Company (i) a $10.0  million
asset  based  revolving  credit  facility  and  (ii) a $3.5  million  term  loan
facility,  both of which have a three year term. The Company  intends to use the
proceeds of the credit  facility to  refinance  the  Company's  existing  credit
facility with Commerce  Bank, to provide  working  capital and for other general
corporate  purposes.  The  commitment  letter is subject  to  certain  customary
conditions to closing,  including satisfactory completion of documentation.  The
definitive  credit  agreement  is expected to contain  affirmative  and negative
covenants  customary  in credit  facilities  of this type and is  expected to be
executed on or before December 15, 2005, subject to normal and customary closing
conditions.


<b>Forward Looking Statements</b>

This  report  contains  forward-looking  statements  within  the  meaning of The
Private  Securities  Litigation Reform Act of 1995. These statements are neither
promises nor guarantees, are based upon assumptions and estimates that might not
be realized and are subject to risks and  uncertainties  that could cause actual
results to differ materially from those in the forward looking statements. These
risks and uncertainties  include,  but are not limited to, the timing of closing
the NCBC credit facility, if at all.








                                    <u>SIGNATURE</u>


          Pursuant to the  requirements of the Securities  Exchange Act of 1934,
     the  Registrant  has duly  caused this report to be signed on its behalf by
     the undersigned hereunto duly authorized.

                                            BLONDER TONGUE LABORATORIES, INC.



                                            By:      <u>   /s/ Eric Skolnik           </u>
                                                     Eric Skolnik
                                                     Senior Vice President and
                                                     Chief Financial Officer

Date: November 3, 2005

</PRE>
</BODY>
</HTML>
[{"type": "8-K", "sequence": "1", "filename": "blonder8k110305.htm", "secsgml_size_bytes": 4120}]
{"company-data": {"conformed-name": "BLONDER TONGUE LABORATORIES INC", "cik": "0001000683", "assigned-sic": "3663", "irs-number": "521611421", "state-of-incorporation": "DE", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "001-14120", "film-number": "051177382"}, "business-address": {"street1": "ONE JAKE BROWN RD", "street2": "PO BOX 1000", "city": "OLD BRIDGE", "state": "NJ", "zip": "08857", "phone": "9086794000"}, "mail-address": {"street1": "ONE JAKE BROWN ROAD", "city": "OLD BRIDGE", "state": "NJ", "zip": "08857"}}
SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                    FORM 8-K

                Current Report Pursuant to Section 13 or 15(d) of
                       the Securities Exchange Act of 1934

       Date of Report (Date of earliest event reported):
October 28, 2005
Blonder Tongue Laboratories, Inc.
             (Exact Name of registrant as specified in its charter)
Delaware
1-14120
52-1611421
(State or other jurisdiction    (Commission File Number)     (I.R.S. Employer
        of incorporation)                                    Identification No.)
One Jake Brown Road, Old Bridge, New Jersey 08857
(Address of principal executive offices) (Zip Code)

       Registrant's telephone number, including area code: (732) 679-4000
Not Applicable
(Former name or former address, if changed since last report)

Check  the  appropriate  box  below  if the  Form  8-K  filing  is  intended  to
simultaneously  satisfy the filing obligation of the registrant under any of the
following provisions:

[_]  Written  communications  pursuant to Rule 425 under the  Securities Act (17
     CFR 230.425)

[_]  Soliciting  material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
     240.14a-12)

[_]  Pre-commencement   communications  pursuant  to  Rule  14d-2(b)  under  the
     Exchange Act (17 CFR 240.14d-2(b))

[_]  Pre-commencement   communications  pursuant  to  Rule  13e-4(c)  under  the
     Exchange Act (17 CFR 240.13e-4(c))
ITEM 1.01.  ENTRY INTO A MATERIAL DEFINITIVE AGREEMENT.
On October 28, 2005, Blonder Tongue  Laboratories,  Inc. (the "Company") entered
into a commitment  letter with  National City Business  Credit,  Inc.  ("NCBC"),
pursuant to which NCBC  committed to provide to the Company (i) a $10.0  million
asset  based  revolving  credit  facility  and  (ii) a $3.5  million  term  loan
facility,  both of which have a three year term. The Company  intends to use the
proceeds of the credit  facility to  refinance  the  Company's  existing  credit
facility with Commerce  Bank, to provide  working  capital and for other general
corporate  purposes.  The  commitment  letter is subject  to  certain  customary
conditions to closing,  including satisfactory completion of documentation.  The
definitive  credit  agreement  is expected to contain  affirmative  and negative
covenants  customary  in credit  facilities  of this type and is  expected to be
executed on or before December 15, 2005, subject to normal and customary closing
conditions.
Forward Looking Statements
This  report  contains  forward-looking  statements  within  the  meaning of The
Private  Securities  Litigation Reform Act of 1995. These statements are neither
promises nor guarantees, are based upon assumptions and estimates that might not
be realized and are subject to risks and  uncertainties  that could cause actual
results to differ materially from those in the forward looking statements. These
risks and uncertainties  include,  but are not limited to, the timing of closing
the NCBC credit facility, if at all.
SIGNATURE
Pursuant to the  requirements of the Securities  Exchange Act of 1934,
     the  Registrant  has duly  caused this report to be signed on its behalf by
     the undersigned hereunto duly authorized.

                                            BLONDER TONGUE LABORATORIES, INC.

                                            By:
/s/ Eric Skolnik
Eric Skolnik
                                                     Senior Vice President and
                                                     Chief Financial Officer

Date: November 3, 2005